1. Introduction {#sec0001}
===============

Currently, the COVID-19 pandemic is in progress. Corona virus disease 2019 or COVID-19, is caused by SARS-COV2, a virus strain belonging to corona virus family ([@bib0053]). As on 25th April 2020, globally there were reported 2.7 million cases and 2 lakh deaths ([@bib0024]). The cases of COVID-19 were initially identified in China ([@bib0060]). It was reported by Chinese Center for disease control (CCDC) on January 7th 2020 as a novel corona virus strain ([@bib0030]). As there was rapid spread of disease to other countries from China, World Health Organization (WHO) identified COVID-19 as Public Health Emergency of International Concern (PHEIC) on 30 January 2020 ([@bib0061]). With further increase in number of cases, number of deaths and the number of countries which affected globally, WHO announced COVID-19 as pandemic on 11 March 2020 ([@bib0062]).

In case of any pandemic situation, prevalence of psychological morbidities tends to be higher compared to normal situations ([@bib0051]). The present circumstances because of COVID-19 pandemic have generated increased worry, stress and fear among population subgroups across the countries. Among general population, there is widespread panic due to lack of knowledge on the situation leading to misconception, misinterpretation, stigma and rumours ([@bib0018]). With increased spread of COVID-19, almost all the affected countries have issued partial or complete lockdown with the aim to adopt social distancing method and break the chain of transmission. Hence, in addition to the disease, the measures taken by the respective countries to fight against this pandemic has also affected the livelihood of the people and this also may directly or indirectly result in increase of psychological morbidities (IASC Reference Group).

Whereas frontline health workers face problems due to increased work load, intense working schedule and increased chance of getting exposed to positive cases ([@bib0030]). The most important subgroup, i.e. the victims of the infection, face the fear of dying from the disease, isolation from family, losing their job, facing discrimination and getting stigmatized by the society (IASC Reference Group). All these problems have in turn increased the fear of social isolation, loneliness, fear of getting the disease and dying, staying away from family, anxiety, depression, stress, insomnia, sleep disturbances and psychological distress. Thus, it is important to address the needs and gaps in mental and psychological aspect of health in all sub-groups of population (general public, health care workers and COVID-19 patients) ([@bib0030]).

In order to understand the psychological needs and gaps, it is important to do a situational analysis of the current scenario by collecting currently available evidence from various countries. Hence, we conducted this review to quantify the prevalence of various psychological morbidities among general population, healthcare workers and COVID-19 patients amidst the COVID-19 pandemic.

2. Methods {#sec0002}
==========

2.1. Design and registration {#sec0003}
----------------------------

We conducted a systematic review and meta-analysis of observational studies. The review protocol was registered on the international prospective register of systematic review (PROSPERO) with registration Number CRD42020182084. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist for reporting systematic reviews incorporating meta-analyses for reporting our review (Supplementary Appendix 1) ([@bib0043]).

2.2. Inclusion criteria for studies considered for the review {#sec0004}
-------------------------------------------------------------

### 2.2.1. Type of studies {#sec0005}

We included research studies reporting the prevalence of various psychological morbidities for the current review. There was no restriction related to study design or age groups. We included studies irrespective of the setting in which the study was conducted or mode of interview (online/offline). Full-text articles, abstracts and preprints were included, while case reports, case series, review articles and unpublished data were excluded.

### 2.2.2. Type of participants {#sec0006}

We included research studies conducted among general population, healthcare workers (doctors, nurses or other paramedical staffs) or patients suffering from COVID-19.

### 2.2.3. Type of outcome measure {#sec0007}

Research studies reporting the following outcome measure were included: stress, depression, anxiety, psychological distress, post-traumatic stress symptoms (PTSS), poor sleep quality, insomnia and impact of event. Studies reporting any of the above outcomes were included irrespective of the scale used for assessment.

2.3. Search strategy {#sec0008}
--------------------

Extensive electronic search was done in the following databases and search engines: MEDLINE, Chinese National Knowledge Infrastructure (CNKI), Cochrane library, ScienceDirect and Google Scholar. Combination of medical subject heading (Mesh) and free text terms were used for carrying out literature search. Complete details on the terms used in the search engines along with the search results obtained were provided in Supplementary Appendix 2. Search was conducted in all the databases from inception to 22 April 2020 with no language restriction for publication. The reference list of primary retrieved articles was checked to gather any relevant articles for inclusion in the review and analysis.

2.4. Selection of studies {#sec0009}
-------------------------

Two independent investigators (YK and RN) performed the literature search and screened the title, abstract and keywords. Full text article was obtained for relevant studies. Further screening of full-text of the retrieved articles was done independently by two investigators (YK and RN) to select the studies satisfying the inclusion criteria. Any disagreements during this selection process were resolved either through consensus or consultation with third investigator (GKS). Quality of the selection process was also monitored by the third investigator (GKS).

2.5. Data extraction and management {#sec0010}
-----------------------------------

Primary investigator (YK) extracted the following study characteristics required for the current review:

1.General Information: Author, study title, publication year, country

2.In Methods section: study design, study period, study setting, study participants, sample size, sampling technique, diagnostic tool, mode of interview, outcome assessment and statistical tests employed

3.In Outcome section: mean age, non-response rate and characteristics, prevalence of stress, anxiety, depression, psychological distress, PTSS, sleep quality, insomnia or impact of event

Primary investigator (YK) transferred these data into the software STATA version 14. Data entry was double checked for correct entry by the second investigator (RN) through comparison of data presented in review and the primary articles.

2.6. Risk of bias assessment in included studies {#sec0011}
------------------------------------------------

Two independent authors (YK and RN) assessed the quality of all the included studies using the Newcastle-Ottawa (NO) scale adapted for cross sectional studies ([@bib0047]). Two criteria (selection and outcome) were used to assess the risk of bias. Following domains were used for assessing the risk of bias under selection criteria: representativeness of the sample, justification of sample size, rate of non-respondents and their characteristics and use of validated measurement tool. Under Outcome criteria, assessment of outcome through independent blind assessment or record linkage was used to assess the risk of bias. Each of these outcomes were rated as high (1 point) or low (0 points) based on the quality of evidence and availability of information. Studies scoring more than or equal to 3 points were considered to have high risk of bias.

2.7. Statistical analysis {#sec0012}
-------------------------

Meta-analysis was performed using the software STATA 14.2 (StataCorp, College Station, TX, USA). For each of the studies, standard error was calculated using the reported number of outcomes and the sample size. The function *"Metaprop"* was used for performing the pooled analysis ([@bib0046]). To minimize the effect of extremely small or large prevalence on the overall estimate, Freeman Tukey double arcsine transformation was done to stabilize the variance ([@bib0046]). Final pooling of data was done with random effects model and reported as proportion with 95% confidence interval (CI).

Evidence of between-study variability was assessed through following methods: Chi-square test for heterogeneity and I^2^ statistic to quantify the inconsistency. I^2^ \< 25% was mild, 25--75% moderate and \>75% was considered substantial heterogeneity ([@bib0015]). Since there was significant heterogeneity with respect to all the outcomes included in our analysis (*p*\<0.05), additional subgroup analysis and meta-regression was performed to explore the potential sources of this heterogeneity. Subgroup analysis was performed based on the study participants (general population/healthcare workers/COVID-19 patients). For meta-regression, the potential covariates were country, diagnostic tool, study participants, sample size, and quality of included studies. Multivariable meta-regression analysis was performed by including the study-level factors with p value less than 0.2 in the univariable model.

Forest plot was used to graphically represent the study specific and pooled prevalence estimates for overall and subgroup analysis. Publication bias was checked and graphically represented by funnel plot and asymmetry of the plot was tested using Egger\'s test-value less than 0.10 was considered as statistically significant publication bias ([@bib0012]).

3. Results {#sec0013}
==========

3.1. Study selection {#sec0014}
--------------------

In total, 3,598 records were screened for their title, abstract and keywords. After removal of duplicates, we reviewed 158 articles' full texts against our eligibility criteria for the possible inclusion in the review. At the same, we reviewed the bibliographies of the retrieved articles and found two more relevant studies. Finally, we analysed data from 50 studies with 171,571 participants satisfying the inclusion criteria ([Fig. 1](#fig0001){ref-type="fig"} ) ([@bib0001]; [@bib0004]; [@bib0004]; [@bib0005]; [@bib0007]; [@bib0008]; [@bib0009]; [@bib0010]; [@bib0013]; [@bib0014]; [@bib0016]; [@bib0017]; [@bib0021]; [@bib0022]; [@bib0023]; [@bib0026]; [@bib0027]; [@bib0033]; [@bib0034]; [@bib0038]; [@bib0036]; [@bib0039]; [@bib0038]; [@bib0037]; [@bib0040]; [@bib0042]; [@bib0044]; [@bib0045]; [@bib0048]; [@bib0049]; [@bib0050]; [@bib0052]; [@bib0055]; [@bib0056]; [@bib0057]; [@bib0058]; [@bib0058]; [@bib0064]; [@bib0065]; [@bib0066]; [@bib0067]; [@bib0068]; [@bib0069]; [@bib0070]; [@bib0071]; [@bib0072]; [@bib0073]; [@bib0074]; [@bib0075]; [@bib0076]).Fig. 1Flow chart Showing the search stratege and selections of studies.Fig. 1

3.2. Characteristics of the studies included {#sec0015}
--------------------------------------------

[Table 1](#tbl0001){ref-type="table"} lists the characteristics of the studies analysed. Majority of the studies (46 out of 50) were conducted in China and one study each in Vietnam, Italy, Singapore and Iran. All the studies were cross-sectional in nature and conducted during the period of COVID-19 pandemic. Most of the studies were conducted among general population and healthcare workers (23 each in each group) and 4 studies among COVID-19 patients. The mean age of study participants ranged from 30.6 to 49.9 years. The sample sizes in the studies varied from 37 to 52,730. Amongst the outcomes, majority of the studies reported anxiety (31 studies) followed by depression (28 studies).Table 1Characteristics of the studies included (*N* = 50).Table 1S.N.First author and yearCountryStudy designMode of interview (online/offline)Study participantsOutcomes reportedAge group (in years)Sample sizeDiagnostic tool1.1Bo 2020ChinaCross Sectional StudyOnlineCOVID-19 PatientsPTSSNA714PCL-C2.[@bib0003]ChinaCross Sectional StudyOfflineHealthcare WorkerDepressionNA37PHQ-93.2[@bib0003]ChinaCross Sectional StudyOnlineGeneral PopulationAnxietyNA7143GAD-74.Chen 2020ChinaCross Sectional StudyOnlineHealthcare WorkerAnxiety, Depression\>18 Years612SDS, SAStype=\"Other\"5.Chung 2020ChinaCross Sectional StudyOnlineHealthcare WorkerDepressionNA69PHQ-96.4Dai 2020ChinaCross Sectional StudyOnlineHealthcare WorkerPsychological Distress20--81 Years4357GHQ 127.Du 2020ChinaCross Sectional StudyOnlineHealthcare WorkerStress, Anxiety, Depression, SleepNA134PSS, Beck Depression Inventory, Beck Anxiety Inventory, Self-Rated Likert Scale8.Gao 2020ChinaCross Sectional StudyOnlineGeneral PopulationAnxiety, Depression18--85 Years4827WHO-5 Well Being Index, GAD-79.Guo 2020ChinaCross Sectional StudyOnlineHealthcare WorkerAnxiety, DepressionNA11,118SDS, SAS10.Hu 2020ChinaCross Sectional StudyOnlineGeneral PopulationAnxiety11--77years992SAS11.Huang 2020ChinaCross Sectional StudyOnlineHealthcare Worker, General PopulationAnxiety, Depression, SleepNA7236CES-D, GAD-7, PQSI12.Jiang 2020ChinaCross Sectional StudyOnlineGeneral PopulationPTSSNA6049PCL-513.Jing 2020ChinaCross Sectional StudyOnlineCOVID-19 PatientsAnxiety, DepressionNA148SDS, SAS14.Jizheng 2020ChinaCross Sectional StudyOnlineHealthcare WorkerAnxiety, PTSSNA230SAS, PTSD-SS15.KONG 2020ChinaCross Sectional StudyOnlineCOVID-19 PatientsAnxiety, Depression15--87 Years144HADS16.Lai 2020ChinaCross Sectional StudyOnlineHealthcare WorkerAnxiety, Depression, Insomnia, DistressNA1257PHQ-9, GAD-7, IES-R, ISI17.Li 2020ChinaCross Sectional StudyOnlineGeneral PopulationAnxiety, DepressionNA3001PHQ-9, GAD-718.[@bib0032]ChinaCross Sectional StudyOnlineHealthcare WorkerAnxietyNA512SAS19.[@bib0032]ChinaCross Sectional StudyOnlineGeneral PopulationSleep, PTSSNA285PQSI20.[@bib0032]ChinaCross Sectional StudyOnlineGeneral PopulationAnxiety, Depression, DistressNA14,592PHQ-9, GAD-7, SRQ-20\
21.[@bib0032]ChinaCross Sectional StudyOnlineHealthcare WorkerAnxiety, Depression, DistressNA4679SDS, SAS, SRQ-2022.Lu 2020ChinaCross Sectional StudyOnlineGeneral PopulationAnxiety, Depression16--65 Years1849CES-D23.Lu 2020ChinaCross Sectional StudyOnlineHealthcare WorkerAnxiety, Depression, SleepNA2150PHQ-9, GAD-724.Lu 2020ChinaCross Sectional StudyOnlineGeneral Population, Healthcare WorkerAnxiety, DepressionNA2299HAMD, HAMA25.Manqin 2020ChinaCross Sectional StudyOnlineGeneral PopulationAnxietyNA3111GAD-726.Mo 2020ChinaCross Sectional StudyOnlineHealthcare WorkerStressNA180SOS27.Naeim 2020IranCross Sectional StudyOfflineGeneral PopulationAnxietyNA807GAD-728.[@bib0045]VietnamCross Sectional StudyOfflineGeneral PopulationDepression18--85 Years3947PHQ29.Qi 2020ChinaCross Sectional StudyOnlineHealthcare WorkerSleep, InsomniaNA1306PSQI, AIS30.Qian 2020ChinaCross Sectional StudyOfflineGeneral PopulationAnxietyNA1011GAD-731.Qiu 2020ChinaCross Sectional StudyOnlineGeneral PopulationDistressNA52,730CPDI32.Rossi 2020ItalyCross Sectional StudyOnlineGeneral PopulationStress, Depression, Anxiety, Insomnia, PTSS\>18 Years18,147PSS, PHQ-9, GAD-7, ISI, GPS33.Sun 2020ChinaCross Sectional StudyOnlineGeneral PopulationPTSSNA2091PCL-534.Tan 2020SingaporeCross Sectional StudyOnlineHealthcare WorkerAnxiety, Depression, Stress, PTSSNA470DASS 21, IES-R35.Tian 2020ChinaCross Sectional StudyOnlineGeneral PopulationDistress13--76 Years1060GSI36.[@bib0059]ChinaCross Sectional StudyOfflineGeneral PopulationAnxiety, Depression, Stress, Impact12--59years1210DASS 21, IES-R37.[@bib0059]ChinaCross Sectional StudyOnlineGeneral PopulationAnxiety, Depression18--72 Years600SDS, SAS38.[@bib0064]ChinaCross Sectional StudyOnlineHealthcare WorkerAnxiety, DepressionNA60Depression Index, Anxiety Index39.Yi 2020ChinaCross Sectional StudyOnlineHealthcare WorkerStress, Anxiety, DepressionNA171PSS, PHQ-9, GAD-740.Yuan 2020ChinaProspective StudyOnlineGeneral PopulationSleepNA939PSQI41.Yuanhai 2020ChinaCross Sectional StudyOnlineHealthcare WorkerDistressNA216Psychological Distress Management Screening Tool42.Yuhong 2020ChinaCross Sectional StudyOnlineGeneral Population,\
COVID-19 Patients, Healthcare WorkerSleepNA362PSQI43.[@bib0069]ChinaCross Sectional StudyOnlineHealthcare WorkerInsomniaNA1563ISI44.[@bib0070]ChinaCross Sectional StudyOnlineHealthcare WorkerInsomnia, Anxiety, DepressionNA2182PHQ 2, GAD-2, ISI45.[@bib0071]ChinaCross Sectional StudyOnlineGeneral PopulationImpact of event\>18 years263IES-R46.[@bib0069]ChinaCross Sectional StudyOnlineGeneral PopulationStressNA1383PSS47.Zhao 2020ChinaCross Sectional StudyOnlineCOVID-19 PatientsDepression, AnxietyNA106PHQ-9, GAD-748.Zheng 2020ChinaCross Sectional StudyOnlineGeneral PopulationDepressionNA86SDS49.Zhu 2020ChinaCross Sectional StudyOnlineHealthcare WorkerStress, Anxiety, DepressionNA5062IES-R, PHQ-9, GAD-750.Zhu 2020ChinaCross Sectional StudyOnlineHealthcare WorkerAnxiety, DepressionNA165SDS, SAS[^1][^2][^3][^4][^5][^6][^7][^8][^9][^10][^11][^12][^13][^14][^15][^16][^17][^18][^19][^20][^21][^22][^23]

3.3. Methodological quality of the included studies {#sec0016}
---------------------------------------------------

We performed assessments of risk of bias for all the included studies using NO scale and reported in [Table 2](#tbl0002){ref-type="table"} . All the 50 studies had high risk of bias related to representativeness of the sample as none of the studies performed random sampling. Only 7 (14%) studies provided proper justification for sample size, 13 (26%) studies reported the non-response rate or their characteristics. All the studies reported use of validated measurement tool. Under the outcome domain, only five studies reported independent assessment of the outcome as majority of studies were conducted as an online survey and self-reported by the participants. Only seven studies (14%) of the included studies had low risk of bias.Table 2Risk of bias assessment for the included studies, *N* = 50.Table 2S.N.First author and yearRepresentativenessSample size justificationNon-responseValidated Measurement toolAssessment of outcome1.1Bo 2020HighHighHighLowHigh2.[@bib0003]HighHighHighLowHigh3.[@bib0003]HighHighLowLowLow4.Chen 2020HighHighHighLowHigh5.Chung 2020HighHighHighLowHigh6.Dai 2020HighHighHighLowHigh7.Du 2020HighHighLowLowHigh8.Gao 2020HighHighLowLowHigh9.Guo 2020HighHighHighLowHigh10.Hu 2020HighHighHighLowHigh11.Huang 2020HighHighHighLowHigh12.Jiang 2020HighHighHighLowHigh13.Jing 2020HighHighHighLowHigh14.Jizheng 2020HighLowLowLowHigh15.KONG 2020HighLowLowLowHigh16.Lai 2020HighLowHighLowHigh17.Li 2020HighHighHighLowHigh18.[@bib0032]HighHighHighLowHigh19.[@bib0032]HighHighHighLowHigh20.[@bib0032]HighHighHighLowHigh21.[@bib0032]HighHighHighLowHigh22.Lu 2020HighHighLowLowHigh23.Lu 2020HighLowHighLowHigh24.Lu 2020HighHighLowLowHigh25.Manqin 2020HighHighHighLowHigh26.Mo 2020HighHighLowLowHigh27.Naeim 2020HighLowLowLowLow28.[@bib0045]HighHighLowLowLow29.Qi 2020HighHighHighLowHigh30.Qian 2020HighLowLowLowLow31.Qiu 2020HighHighHighLowHigh32.Rossi 2020HighHighHighLowHigh33.Sun 2020HighHighHighLowHigh34.Tan 2020HighHighLowLowHigh35.Tian 2020HighHighHighLowHigh36.[@bib0059]HighLowHighLowLow37.[@bib0059]HighHighHighLowHigh38.[@bib0064]HighHighHighHighHigh39.YUAN 2020HighHighHighLowHigh40.Yi 2020HighHighHighLowHigh41.Yuanhai 2020HighHighHighLowHigh42.Yuhong 2020HighHighHighLowHigh43.Zhang 2020HighHighHighLowHigh44.Zhang 2020HighHighHighLowHigh45.Zhang 2020HighHighLowLowHigh46.Zhang 2020HighHighHighLowHigh47.Zhao 2020HighHighHighLowHigh48.Zheng 2020HighHighHighLowHigh49.Zhu 2020HighHighHighLowHigh50.Zhu 2020HighHighHighLowHigh

3.4. Prevalence of psychological morbidities amidst the COVID-19 pandemic {#sec0017}
-------------------------------------------------------------------------

[Table 3](#tbl0003){ref-type="table"} shows the prevalence of psychological morbidities across various subgroups during the COVID-19 pandemic. The overall prevalence of stress amidst the COVID-19 pandemic was 34% (95%CI: 20%−50%). Subgroup analysis showed that this burden was higher among the general population (36%; 95%CI: 5%−75%) compared to healthcare workers (33%; 95%CI: 19%−50%).No studies have reported stress among COVID-19 patients (Appendix 3.1& 3.2).Table 3Summary of findings among studies reporting psychological morbidities amidst the COVID-19 pandemic.Table 3OutcomeNumber of studies pooledPooled ES[\#](#tb3fn1){ref-type="table-fn"} (95% CI)I^2^Figure***Stress****General population*336% (5%−75%)NAAppendix 3.1*Healthcare workers*533% (19%−50%)98.4%Appendix 3.1*Overall*834% (20%−50%)99.7%Appendix 3.2***Depression****General population*1224% (14%−36%)99.9%Appendix 3.3*Healthcare workers*1625% (19%−32%)99.4%Appendix 3.3*COVID-19 patients*342% (28%−57%)NAAppendix 3.3*Overall*2826% (20%−33%)99.8%Appendix 3.4***Anxiety****General population*1526% (20%−32%)99.7%Appendix 3.5*Healthcare workers*1624% (16%−32%)99.6%Appendix 3.5*COVID-19 patients*337% (19%−57%)NAAppendix 3.5*Overall*3126% (21%−31%)99.7%Appendix 3.6***Psychological distress****General population*326% (21%−32%)NAAppendix 3.7*Healthcare workers*441% (19%−65%)99.8%Appendix 3.7*Overall*734% (27%−42%)99.7%Appendix 3.8***PTSS****General population*415% (4%−31%)99.8%Appendix 3.9*Healthcare workers*213% (11%−16%)NAAppendix 3.9*COVID-19 patients*196% (95%−97%)NAAppendix 3.9*Overall*727% (12%−45%)99.8%Appendix 3.10***Poor sleep quality****General population*434% (12%−60%)99.5%Appendix 3.11*Healthcare workers*543% (28%−59%)99.2%Appendix 3.11*COVID-19 patients*182% (66%−92%)NAAppendix 3.11*Overall*740% (25%−57%)99.6%Appendix 3.12***Insomnia****General population*17% (7%−8%)NAAppendix 3.13*Healthcare workers*437% (32%−42%)92.6%Appendix 3.13*Overall*530% (12%−52%)99.9%Appendix 3.14***Impact of event****Overall*244% (42%−47%)NAAppendix 3.15[^24][^25]

The pooled prevalence of depression was 26% (95%CI: 20%−33%).COVID-19 patients had the highest burden of depression (42%; 95%CI: 28%−57%) followed by healthcare workers (25%; 95%CI: 19%−32%) and general population (24%; 95%CI: 14%−36%) (Appendix 3.3 & 3.4). The pooled prevalence of anxiety disorder amidst the COVID-19 pandemic was 26% (95%CI: 21%−31%).Here also, the burden was highest among COVID-19 patients (37%; 95%CI: 19%−57%) followed by general population (26%; 95%CI: 20%−32%) and healthcare workers (24%; 95%CI: 16%−32%) (Appendix 3.5& 3.6).

The overall burden of psychological distress was 34% (95%CI: 27%−42%), and it was more common among healthcare workers (41%; 95%CI: 19%−65%) compared to general population (26%; 95%CI: 21%−32%) (Appendix 3.7 & 3.8). The pooled prevalence of PTSS was 27% (95%CI: 12%−45%) with maximum burden in COVID-19 patients (96%; 95%CI: 95%−97%) followed by general population (15%; 95%CI: 4%−31%) and healthcare workers (13%; 95%CI: 11%−16%) (Appendix 3.9 & 3.10). Poor sleep quality was prevalent among 40% (95%CI: 25%−57%) of the population. Maximum burden of poor sleep quality was among COVID-19 patients (82%; 95%CI: 66%−92%) followed by healthcare workers (43%; 95%CI: 28%−59%) and general population (34%; 95%CI: 12%−60%) (Appendix 3.11 & 3.12). The pooled prevalence of insomnia was 30% (95%CI: 12%−52%) with maximum impact among healthcare workers (37%; 95%CI: 32%−42%) followed by general population (7%; 95%CI: 7%−8%) (Appendix 3.13& 3.14). The impact of the COVID-19 pandemic affected the mental health of 44% (95%CI: 42%−47%) of the general population (Appendix 3.15).

3.5. Additional subgroup analysis {#sec0018}
---------------------------------

Apart from the study population, subgroup analysis was also performed for online/offline version of study and country in which the studies were conducted. However, it could be performed only for anxiety and depression as other outcomes did not have enough number of studies to perform this analysis.

First, based on online/offline version of studies, there was no significant difference in the pooled prevalence of anxiety as the studies conducted through online survey had pooled prevalence of 25% while offline studies had prevalence of 28% (Appendix 3.16). However, the pooled prevalence of depression differed significantly as the online version of studies reported high prevalence of 28% and offline version only 13% (Appendix 3.17). However, for both the outcomes, only 3 studies were available in offline version and more such studies required to comment on this difference in outcome.

Based on the country also, anxiety did not show significant difference in pooled estimate (China=26%; Other countries=21%), while pooled prevalence of depression was significantly higher among studies conducted in China (29%) compared to other countries (11%) (Appendix 3.18& 3.19).

3.6. Meta-regression {#sec0019}
--------------------

Meta-regression was performed for only two outcomes such as anxiety and depression as the other outcomes did not have sufficient number of studies. First, for anxiety, we conducted univariable meta-regression with individual study level factors such as country, diagnostic tool, study participants, sample size, and quality of evidence. Multivariable meta-regression was performed with factors having p value less than 0.2 which included country, diagnostic tool, study participants and sample size. The adjusted model was able to explain 26.4% of the between-study variability and the model was statistically significant (*p* = 0.02).

Second, for depression, univariable regression was performed with the above-mentioned factors and only country, study participants and diagnostic tool satisfied the criteria for multivariable meta-regression. Here also, the adjusted model was significant and able to explain 20.5% of the between-study variability (*p* = 0.03).

3.7. Publication bias {#sec0020}
---------------------

Publication bias was also assessed for only two outcomes (anxiety and depression) as the other outcomes did not have sufficient number of studies. There were no small study effects with non-significant coefficient value for both anxiety (*p* = 0.83) and depression (*p* = 0.89). This shows that there is a possibility of absence of publication bias. Graphical representation of the test of publication bias was depicted through funnel plot in Appendix 3.20 & 3.21. Funnel plot also showed symmetric plot indicating the absence of publication bias.

4. Discussion {#sec0021}
=============

This study found that globally the burden of mental and psychological problems is an important health issue and more common amidst this COVID-19 pandemic. Nearly half of the general public have reported that there was a significant psychological impact due to COVID-19 pandemic. Poor sleep quality (40%) was the most common problem faced by the people followed by stress (34%) and psychological distress (34%). The burden of psychological morbidity was highest among the COVID-19 patients followed by healthcare workers and general population.

In case of a pandemic situation, due to widespread occurrence of disease and increased number of cases and deaths, it is common to observe higher psychological morbidities in the population sub-groups, but it has to be quantified. Similar situations with higher psychological morbidities were also found in the past during the outbreaks of severe acute respiratory syndrome (SARS), H1N1 influenza, Ebola virus, middle east respiratory syndrome (MERS) ([@bib0002]). There was an alarming rise in the prevalence of psychological morbidity among the patients compared to healthcare workers or general public similar to previous outbreaks ([@bib0028]). More than half of the patients affected with SARS, MERS or Ebola had at least one of the many psychological morbidities such as depression, anxiety, stress or sleep problems ([@bib0006]; [@bib0025]; [@bib0019]). Major factors responsible for such high burden among the patients are the perception of threat, mortality level, food insecurity, stigma and discrimination. In addition, as the COVID-19 has no definitive therapeutic agent or vaccine, there is always an uncertainty on the outcome among the patients which can further worsen their mental status. This shows that the mental health needs to be an integral part of rehabilitation of patients following the outbreak. There is also a pressing need to enhance the preparedness and competence of health care workers (including non-psychiatrists) to detect these problems early. Further research is required to study long term mental health sequelae amongst the survivors.

After patients, highest burden of psychological morbidity was found among healthcare workers compared to general public. Previous surveys during epidemics have also reported that healthcare workers have significantly higher prevalence of psychological problems compared to general population ([@bib0020]; [@bib0029]; [@bib0031]; [@bib0054]). World Health Organization has informed that there is severe shortage of personal protective equipment (PPE) around the world, as a result of rising demand, misuse, panic buying and hoarding ([@bib0063]). Therefore, healthcare workers mental status depends on PPE availability to prevent them from getting infected and infecting others. Without this, they will be at risk, and this situation severely impacts their physical and mental health. Even in settings with adequate PPE and intensive training before handling any patients, still there is a possibility of getting disease. Apart from the concerns related to personal protection, safety of their loved ones, death of their own colleagues, excess working hours, worrying about the domestic supplies, ethical concerns about rationing of ventilators for the sick might exert a negative impact on their psychological status ([@bib0041]).

Apart from patients and healthcare workers, even the general public have higher prevalence of psychological morbidities during this pandemic period compared to normal times. This was similar to the findings in previous epidemics ([@bib0002]; [@bib0035]). Stress (36%) is the most common psychological problem among general public followed by poor sleep quality (34%), psychological distress (34%), anxiety (26%) and depression (24%). Possible reason for such high burden during pandemic period is the prolonged duration of quarantine. Quarantine is an unpleasant experience among those who undergo it. There is loss of freedom, separation from families and friends, boredom, and uncertainty over their disease status. There can also stressors related to finances, employment, fear and stigma attached to the condition. Previous review on psychological impact of quarantine during previous outbreaks have shown that there is significantly higher prevalence among those general public who are under quarantine ([@bib0002]). The prevalence increased with increase in duration of quarantine. Hence, the potential benefit of introducing a large-scale quarantine should be assessed along with possible psychological consequences attached with it.

The major strength of the study is that we have tried to provide the first comprehensive review on burden of psychological morbidities during the COVID-19 pandemic. We also provided estimates stratified based on the general public, healthcare workers and COVID-19 patients. Test for publication bias have found that there was no significant bias in the current review. However, it could not be assessed for all the outcomes owing to limitation of number of studies.

Our review has certain limitations. Summarizing and concluding the prevalence of psychological morbidities with a single point estimate is difficult because of the inherent heterogeneity. We have tried to overcome this limitation by conducting subgroup analysis and meta-regression based on study-level factors and thus, examined potential sources of heterogeneity. There was lack of representation of studies in countries other than China. Almost 90% of the studies included in our review had high risk of bias mainly because of online mode of recruitment and data collection. All the included studies have used validated screening tool to identify the psychological morbidity. None of the studies used confirmation tool such as diagnostic and statistical manual of psychiatric disorders -- 5 (DSM-5) to confirm the diagnosis. However, in such pandemic situation, it is the feasible way to conduct studies as the direct contact and confirmation may not be always possible with all the participants.

In spite of these limitations, this review provides important baseline information of various psychological morbidities suffered by the general public, healthcare workers and COVID-19 patients amidst this pandemic period. This will act as a tool for policymakers to develop and provide guidance to the public. Rapid and effective risk communication should be provided to the public, so that the negative effects of public health measures taken during this pandemic gets neutralized. Both general and medical supplies should be ensured. People under lockdown should be advised about stress management and coping strategies.

Healthcare workers deserves a special attention as the evidences suggest that they can be negatively influenced by the stigmatizing attitudes from the general public. All the frontline workers should work together to enact effective strategies to promote their psychological well-being. During such outbreaks, support from the organization has been proven to be effective in protecting their mental health. Hence, the organization should make sure that they are adequately supported by their staff members and colleagues. They should have a proper plan, policy, and standard operating procedure in place for their workers. Employer institution can arrange for quarantine facilities or accommodation for their staffs. They can also make a support cell, which will provide a platform for workers to exchange and address their concerns, normalize their feelings related to the stressful environment, share helpful stress coping strategies, and discuss about the maladaptive responses.

COVID-19 patients face the maximum mental health trauma during and after the course of their illness. Survivors of COVID-19 patients can have a long-term impact on their mental health. Once the situation improves in any particular region, survivors should be followed up and evaluated for a longer period of time so that the negative psychological consequences are kept in check. Comprehensive strategic plan to ensure good mental health should be developed. This should address behavioural, social and psychological issues related to COVID-19. Hence, in addition to the medical facilities, psychological services for patients, family members, healthcare workers should be developed, implemented and sustained.

Suicidal ideation can be a pressing concern with the growing pandemic across all the subgroups ([@bib0011]). Mental healthcare services need a clear assessment and care pathways for people with suicidal ideation, and training of staffs to support newer ways of working. Digital training materials enables the staffs who have not previously worked with people having suicidal ideation to take effective role in helplines and mental healthcare services. Evidence based online applications and interventions should be developed and provided to support the people who are suicidal risk.
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[^1]: NA: Not Available.

[^2]: PTSS: Post Traumatic Stress Syndrome.

[^3]: PCL-C: PTSD CheckList -- Civilian Version.

[^4]: GAD: General Anxiety Disorder.

[^5]: PHQ: Patient Health Questionnaire.

[^6]: SDS: Zung Self- Rating Depression scale.

[^7]: SAS: Zung Self Rating Anxiety Scale.

[^8]: GHQ: General Health Questionnaire.

[^9]: PSS: Perceived Stress Scale.

[^10]: WHO: World Health Organization.

[^11]: CES-D: Center for Epidemiologic Studies Depression Scale.

[^12]: PSQI: Pittsburgh Sleep Quality Index.

[^13]: PTSD-SS: Self-Assessment Scale for Posttraumatic Stress Disorder.

[^14]: HADS: Hospital Anxiety and Depression Scale.

[^15]: IES-R: Impact of Event Scale - Revised.

[^16]: ISI: Insomnia Severity Index.

[^17]: SRQ: Self- Reporting Questionnaire.

[^18]: HAMD: Hamilton Depression rating scale.

[^19]: HAMA: Hamilton Anxiety Rating Scale.

[^20]: SOS: Stress Overload scale.

[^21]: AIS: Athens Insomnia Scale.

[^22]: CPDI: COVID-19 Peritraumatic Distress Index.

[^23]: GPS: Global Psychotrauma Screen; DASS: Depression Anxiety Stress Scale; GSI: Global Severity Index.

[^24]: NA-Not applicable.

[^25]: Effect Size.
